Sign in with Google
|
USD 2.90
Price
0.06
(2.11%)
Day Change
|
|
|---|
PBYI, the overall quality is good (Quality = 77) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
66% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 2 |
| Magic Formula Rank by ROA |
163
|
| Magic Formula Rank by ROE |
163
|
| Magic Formula Rank by ROIC |
53
GOOD
|
| Price | 2.90 |
| PBV / Sector |
1.96 / 1.77
|
| Earning Per Share | 0.47 |
| PE / Sector |
6.04 / 16.78
GREAT
|
| PEG or PE/Growth / Sector |
0.03 / 5.46
GREAT
|
| Average 1M Daily Value |
1.68 M
GREAT
|
| Average 1W Daily Value |
1.71 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2024-11-21 20:05:22 |
| Symbol | PBYI |
| Name | PUMA BIOTECHNOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 49.09 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 139.41 / 3,489.12 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
UTHR 
